Mankind Pharma's ₹ 2.91 Crore GST Penalty Withdrawn on Appeal
The withdrawal of a penalty of ₹ 2,90,70,363/- represents a direct financial saving for the company, which is a moderately positive event.
The company successfully appealed a GST order, resulting in the withdrawal of an entire penalty amount of ₹ 2,90,70,363/-.
* Mankind Pharma Limited announced on 10 September 2025, that it has received an order from the Office of the Commissioner (Appeals), CGST, Meerut, regarding an appeal filed against an earlier Goods and Services Tax (GST) order. * The original Order-in-Original, passed by the Additional Commissioner, CGST Commissionerate, Meerut, on 14 November 2024, had imposed a penalty of ₹ 2,90,70,363/-. * This penalty covered the Financial Years 2017-18 to 2021-22. * The recent order from the Commissioner (Appeals) has resulted in the withdrawal of the entire penalty amount of ₹ 2,90,70,363/-.
What to do with a filing like this
Mankind Pharma Limited filed this with the NSE as a statutory disclosure, categorised under legal. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Mankind Pharma Limited. Read the original for the full detail.